In the event of a dog bite, a person needs more than just the rabies vaccine. Experts highlight the importance of ...
A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...
Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...